IRS
IRSA Inversiones y Representaciones S.A.
13.40$
+1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in ARS.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110.64 | 1,539.98 | 1,418.90 | 159.52 | 1,615.48 | 1,791.06 | 1,247.97 | 1,600.36 | 1,529.62 | 1,806.62 | 1,674.68 | 30,058.56 | 84,415.79 | |
| 39.96 | 617.62 | 570.62 | 55.63 | 583.44 | 718.31 | 501.88 | 2,401.42 | 590.54 | 669.71 | 683.68 | 12,055.86 | 33,143.13 | |
| 70.68 | 922.36 | 848.28 | 103.89 | 1,032.04 | 1,072.75 | 746.09 | 1,600.36 | 939.08 | 1,136.92 | 990.99 | 18,002.70 | 51,272.66 | |
| 12.01 | 218.21 | 201.25 | 30.23 | 197.10 | 253.79 | 177.00 | 324.40 | 165.66 | 260.04 | 273.64 | 2,958.66 | 10,544.93 | |
| 301.61 | 214.84 | -1,261.27 | 106.11 | 4,403.90 | 249.86 | -1,109.32 | -727.04 | -2,306.59 | 835.94 | 295.45 | 29,368.76 | 16,620.41 | |
| -230.93 | 707.52 | 2,109.55 | 118.22 | -3,371.86 | 822.90 | 1,855.41 | 2,327.40 | 3,245.67 | 300.98 | 695.55 | -11,366.06 | 34,652.25 | |
| 4.55 | 117.68 | 232.40 | 48.92 | 148.76 | 149.65 | 6.68 | 358.43 | 149.65 | 250.03 | 263.12 | 2,910.17 | 10,100.13 | |
| -202.40 | 1,367.74 | 1,863.62 | 155.59 | -2,955.27 | 1,590.75 | 1,639.11 | 2,409.36 | 2,915.73 | 968.66 | -506.60 | 36,658.42 | 73,299.87 | |
| -68.17 | 339.55 | 795.89 | – | -995.34 | 394.92 | 700.01 | 304.39 | 981.65 | 110.27 | -128.81 | 8,811.66 | 19,259.18 | |
| -130.06 | 995.23 | 1,028.16 | 120.08 | -1,899.01 | 1,157.50 | 904.30 | 2,114.26 | 1,820.58 | 823.07 | -350.14 | 25,635.34 | 50,514.76 | |
| -186.53 | 1,569.87 | 1,909.92 | – | -2,723.63 | 1,825.76 | 1,663.32 | – | 3,123.14 | 1,260.27 | -197.80 | 41,587.10 | 86,991.66 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.